Opaleye Management’s TELA Bio TELA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-750,000
Closed -$6M 51
2023
Q3
$6M Sell
750,000
-830,000
-53% -$7.71M 1.95% 13
2023
Q2
$16M Sell
1,580,000
-492,813
-24% -$5.04M 3.83% 4
2023
Q1
$22.1M Hold
2,072,813
6.61% 3
2022
Q4
$23.8M Buy
2,072,813
+36,262
+2% +$325K 8.29% 2
2022
Q3
$17.4M Buy
2,036,551
+393,184
+24% +$3.26M 7.17% 4
2022
Q2
$11.5M Buy
1,643,367
+1,166,367
+245% +$9.68M 5.19% 6
2022
Q1
$5.55M Buy
477,000
+27,133
+6% +$328K 1.72% 19
2021
Q4
$5.76M Buy
449,867
+6,668
+2% +$84.5K 1.22% 26
2021
Q3
$6.05M Buy
443,199
+2,734
+0.6% +$38.1K 1.13% 27
2021
Q2
$7.1M Buy
440,465
+75,465
+21% +$1.03M 1.18% 28
2021
Q1
$5.44M Hold
365,000
0.8% 36
2020
Q4
$5.49M Buy
365,000
+2,926
+0.8% +$47.5K 0.72% 37
2020
Q3
$5.99M Buy
362,074
+112,074
+45% +$1.57M 1.17% 31
2020
Q2
$3.24M Buy
250,000
+169,000
+209% +$2.22M 0.65% 39
2020
Q1
$633K Sell
81,000
-94,000
-54% -$1.27M 0.17% 41
2019
Q4
$2.27M Buy
+175,000
New +$2.14M 0.44% 43

Other funds holding TELA

Opaleye Management's TELA Position: Q4 2023 in Review

Opaleye Management sold out of TELA Bio (TELA) in Q4 2023, closing a stake of 750,000 shares — an estimated $6M sold.

Opaleye Management first reported a position in TELA in Q4 2019 and held it in 16 quarters. The position peaked at $23.8M in Q4 2022. 60 funds tracked by Wall St. Rank hold TELA as of Q4 2023.

  • Opaleye Management reported no remaining TELA Bio position as of Q4 2023 after selling out during the quarter.
  • Opaleye Management sold 750,000 TELA Bio shares in Q4 2023, an estimated $6M.
  • Opaleye Management first reported a position in TELA Bio in Q4 2019 and held it in 16 quarters.
  • Opaleye Management's TELA Bio position peaked at $23.8M in Q4 2022.
  • 60 funds tracked by Wall St. Rank held TELA Bio as of Q4 2023.

Based on Opaleye Management's 13F filing for Q4 2023, filed 14 Feb 2024.